SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-24-079033 from Haoxi Health Technology Ltd (HAO)

Haoxi Health Technology Ltd
Date: Sept. 16, 2024 · CIK: 0001954594 · Accession: 0001213900-24-079033

AI Filing Summary & Sentiment

File numbers found in text: 333-280174

Date
September 16, 2024
Author
Not clearly detected
Form
CORRESP
Company
Haoxi Health Technology Ltd

Letter

September 16, 2024

VIA EDGAR CORRESPONDENCE

Division of Corporate Finance

Office of Trade and Services

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Attention: Nicholas Nalbantian

Dietrich King

Re: Haoxi Health Technology Limited

Registration Statement on Form F-1

(File No. 333-280174)

REQUEST FOR ACCELERATION OF EFFECTIVENESS

Ladies and Gentlemen:

In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, EF Hutton LLC, as representative of the underwriters (the “Representative”), hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:30 p.m., Eastern Time, on September 18, 2024, or as soon thereafter as practicable.

Pursuant to Rule 460 under the Act, we wish to advise you that the Representative has distributed as many copies of the preliminary prospectus to underwriters, dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.

EF Hutton LLC

By: /s/ Stephanie Hu

Name: Stephanie Hu

Title: Co-Head of Investment Banking

Show Raw Text
CORRESP
1
filename1.htm

September 16, 2024

VIA EDGAR CORRESPONDENCE

Division of Corporate Finance

Office of Trade and Services

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

    Attention:
    Nicholas Nalbantian

    Dietrich King

    Re:
    Haoxi Health Technology Limited

    Registration Statement on Form F-1

    (File No. 333-280174)

    REQUEST FOR ACCELERATION OF EFFECTIVENESS

Ladies and Gentlemen:

In accordance with Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, EF Hutton LLC, as representative of the underwriters
(the “Representative”), hereby requests acceleration of the effective date of the above-referenced Registration Statement
so that it will become effective at 5:30 p.m., Eastern Time, on September 18, 2024, or as soon thereafter as practicable.

Pursuant to Rule 460 under
the Act, we wish to advise you that the Representative has distributed as many copies of the preliminary prospectus to underwriters, dealers,
institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned confirms
that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that
they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection
with the above-referenced issue.

    EF Hutton LLC

    By:
    /s/ Stephanie Hu

    Name:
    Stephanie Hu

    Title:
    Co-Head of Investment Banking